NPI: 1285009035 · MODESTO, CA 95355 · Clinical Medical Laboratory · NPI assigned 12/04/2015
Authorized official LOPES, KRISTA controls 20+ related entities in our dataset. Read more
| Authorized Official | LOPES, KRISTA (SH VP, QUALITY, SAFETY AND PATIENT) |
| NPI Enumeration Date | 12/04/2015 |
Other providers sharing the same authorized official: LOPES, KRISTA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 2,308 | $8K |
| 2019 | 1,924 | $6K |
| 2020 | 1,727 | $47K |
| 2021 | 3,864 | $105K |
| 2022 | 2,314 | $51K |
| 2023 | 5,114 | $47K |
| 2024 | 5,511 | $39K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 1,447 | 1,382 | $117K |
| 80053 | Comprehensive metabolic panel | 4,318 | 3,769 | $31K |
| 80061 | Lipid panel | 2,032 | 1,999 | $25K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4,094 | 3,613 | $22K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,755 | 1,664 | $17K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 309 | 298 | $15K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 111 | 110 | $13K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 360 | 357 | $9K |
| 86803 | 426 | 398 | $6K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 23 | 23 | $6K |
| 87634 | 27 | 27 | $5K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 460 | 440 | $5K |
| 80048 | Basic metabolic panel (calcium, ionized) | 767 | 731 | $5K |
| 81001 | 1,070 | 1,024 | $4K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 131 | 130 | $3K |
| 84443 | Thyroid stimulating hormone (TSH) | 339 | 331 | $3K |
| 87081 | 194 | 194 | $2K | |
| 86481 | 12 | 12 | $2K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 40 | 39 | $2K |
| 87186 | 193 | 189 | $2K | |
| 86140 | 324 | 300 | $2K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 27 | 27 | $2K |
| 87077 | 115 | 112 | $869.67 | |
| 80074 | 12 | 12 | $673.48 | |
| 87400 | 37 | 37 | $565.88 | |
| 82607 | 85 | 84 | $550.72 | |
| 82728 | 95 | 94 | $540.02 | |
| 36415 | Collection of venous blood by venipuncture | 2,173 | 1,894 | $407.62 |
| 85652 | 323 | 311 | $355.25 | |
| 81003 | 128 | 126 | $326.87 | |
| 82570 | 154 | 153 | $173.67 | |
| 86038 | 15 | 13 | $145.81 | |
| 86762 | 13 | 13 | $104.18 | |
| 86735 | 13 | 13 | $93.35 | |
| 86765 | 13 | 13 | $92.20 | |
| 82043 | 76 | 75 | $90.71 | |
| 87070 | 56 | 56 | $89.41 | |
| 83735 | 20 | 17 | $76.43 | |
| 83550 | 41 | 40 | $73.18 | |
| 83540 | 42 | 41 | $60.99 | |
| 85027 | 16 | 15 | $43.93 | |
| 71046 | Radiologic examination, chest; 2 views | 199 | 197 | $0.00 |
| 70450 | Computed tomography, head or brain; without contrast material | 72 | 69 | $0.00 |
| 99233 | Prolong inpt eval add15 m | 149 | 84 | $0.00 |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 88 | 87 | $0.00 |
| 99223 | Prolong inpt eval add15 m | 32 | 30 | $0.00 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 17 | 14 | $0.00 |
| 71045 | Radiologic examination, chest; single view | 197 | 172 | $0.00 |
| 99239 | Hospital discharge day management, more than 30 minutes | 35 | 35 | $0.00 |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 47 | 46 | $0.00 |
| 99232 | Subsequent hospital care, per day, moderate complexity | 40 | 24 | $0.00 |